Actoplus MET (Pioglitazone Hydrochloride / Metformin Hydrochloride) - Published Studies

Actoplus MET Related Published Studies

Well-designed clinical trials related to Actoplus MET (Pioglitazone / Metformin)

Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM. [2009.10.14]

Other research related to Actoplus MET (Pioglitazone / Metformin)

Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditions. [2009.06]

Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England. [2008]

A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control. [2006]

Pioglitazone/metformin. [2006]

Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a german statutory healthcare perspective. [2004]

Other possibly related research studies

Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes. [2007]